ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,567.80
(
0.38%
)
US Tech 100
15,534.40
(
-0.37%
)
Dow Jones
35,950.89
(
1.47%
)
Brent Oil
80.37
(
-2.78%
)
Bitcoin
37,732.98
(
-0.36%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) News

PSNL

Personalis (PSNL)

Personalis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateTimeSourceHeadlineSymbolCompany
11/28/20234:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
11/28/20234:15PMBusiness WirePersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer TestingNASDAQ:PSNLPersonalis Inc
11/20/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
11/20/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
11/07/20234:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
11/07/20234:01PMBusiness WirePersonalis Reports Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
11/07/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
10/26/20238:15AMBusiness WirePersonalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in CancerNASDAQ:PSNLPersonalis Inc
10/24/20234:01PMBusiness WirePersonalis to Announce Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
10/21/20234:25AMBusiness WireAnalysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD TechnologyNASDAQ:PSNLPersonalis Inc
10/19/20237:15AMBusiness WirePersonalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023NASDAQ:PSNLPersonalis Inc
10/18/20237:15AMBusiness WirePersonalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical ComplianceNASDAQ:PSNLPersonalis Inc
08/29/20234:01PMBusiness WirePersonalis to Present at the 21st Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
08/28/20235:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
08/24/20237:01PMBusiness WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/08/20234:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
08/08/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
08/08/20234:01PMBusiness WirePersonalis Reports Second Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/02/20234:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
08/01/20234:01PMBusiness WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
07/25/20234:01PMBusiness WirePersonalis to Announce Second Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
06/26/20235:00PMBusiness WirePersonalis Files Second Patent Infringement Suit Against Foresight DiagnosticsNASDAQ:PSNLPersonalis Inc
06/21/20234:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
06/14/20236:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
06/14/20236:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSNLPersonalis Inc
06/13/20237:01PMBusiness WireDr. Kenneth J. Widder Joins Personalis Board of DirectorsNASDAQ:PSNLPersonalis Inc
06/09/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSNLPersonalis Inc
05/30/20238:00AMBusiness WirePersonalis Announces Two Abstracts Accepted for Presentation at ASCO 2023NASDAQ:PSNLPersonalis Inc
05/19/20237:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
05/19/20236:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Your Recent History

USOTC
GDVM
Global Developments (PK)
USOTC
RDGL
Vivos (QB)
USOTC
ATMH
All Things Mobile Analytic (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
RAKR
Rainmaker Worldwide (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
TONR
Tonner One World (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
SRNW
Stratos Renewables (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com